280 related articles for article (PubMed ID: 22283566)
1. Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner.
Michels T; Shurin GV; Naiditch H; Sevko A; Umansky V; Shurin MR
J Immunotoxicol; 2012; 9(3):292-300. PubMed ID: 22283566
[TBL] [Abstract][Full Text] [Related]
2. Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.
Zhong H; Gutkin DW; Han B; Ma Y; Keskinov AA; Shurin MR; Shurin GV
Int J Cancer; 2014 Jun; 134(11):2633-45. PubMed ID: 24443321
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
[TBL] [Abstract][Full Text] [Related]
4. Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice.
Sevko A; Kremer V; Falk C; Umansky L; Shurin MR; Shurin GV; Umansky V
J Immunotoxicol; 2012; 9(3):275-81. PubMed ID: 22449053
[TBL] [Abstract][Full Text] [Related]
5. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
Fernández A; Oliver L; Alvarez R; Fernández LE; Lee KP; Mesa C
Hum Vaccin Immunother; 2014; 10(11):3251-60. PubMed ID: 25483674
[TBL] [Abstract][Full Text] [Related]
6. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.
Sevko A; Michels T; Vrohlings M; Umansky L; Beckhove P; Kato M; Shurin GV; Shurin MR; Umansky V
J Immunol; 2013 Mar; 190(5):2464-71. PubMed ID: 23359505
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells.
Shirota Y; Shirota H; Klinman DM
J Immunol; 2012 Feb; 188(4):1592-9. PubMed ID: 22231700
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
[TBL] [Abstract][Full Text] [Related]
10. Targeting immune suppressing myeloid-derived suppressor cells in oncology.
Kao J; Ko EC; Eisenstein S; Sikora AG; Fu S; Chen SH
Crit Rev Oncol Hematol; 2011 Jan; 77(1):12-9. PubMed ID: 20304669
[TBL] [Abstract][Full Text] [Related]
11. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4.
Bunt SK; Clements VK; Hanson EM; Sinha P; Ostrand-Rosenberg S
J Leukoc Biol; 2009 Jun; 85(6):996-1004. PubMed ID: 19261929
[TBL] [Abstract][Full Text] [Related]
12. Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer.
Ugolini A; Tyurin VA; Tyurina YY; Tcyganov EN; Donthireddy L; Kagan VE; Gabrilovich DI; Veglia F
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32584791
[TBL] [Abstract][Full Text] [Related]
13. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
Li H; Han Y; Guo Q; Zhang M; Cao X
J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
[TBL] [Abstract][Full Text] [Related]
14. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
[TBL] [Abstract][Full Text] [Related]
15. Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions.
Zhou J; Wu J; Chen X; Fortenbery N; Eksioglu E; Kodumudi KN; Pk EB; Dong J; Djeu JY; Wei S
Int Immunopharmacol; 2011 Jul; 11(7):890-8. PubMed ID: 21244860
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies.
Hossain F; Al-Khami AA; Wyczechowska D; Hernandez C; Zheng L; Reiss K; Valle LD; Trillo-Tinoco J; Maj T; Zou W; Rodriguez PC; Ochoa AC
Cancer Immunol Res; 2015 Nov; 3(11):1236-47. PubMed ID: 26025381
[TBL] [Abstract][Full Text] [Related]
17. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
[TBL] [Abstract][Full Text] [Related]
18. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
[TBL] [Abstract][Full Text] [Related]
19. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy.
Raber PL; Sierra RA; Thevenot PT; Shuzhong Z; Wyczechowska DD; Kumai T; Celis E; Rodriguez PC
Oncotarget; 2016 Apr; 7(14):17565-78. PubMed ID: 27007050
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice.
Godoy HE; Khan AN; Vethanayagam RR; Grimm MJ; Singel KL; Kolomeyevskaya N; Sexton KJ; Parameswaran A; Abrams SI; Odunsi K; Segal BH
PLoS One; 2013; 8(7):e69631. PubMed ID: 23922763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
